Current state of diagnostic, screening and surveillance testing methods for COVID-19 from an analytical chemistry point of view

Autor: Noelia Tena, Julia Martín, Agustin G. Asuero
Rok vydání: 2021
Předmět:
Antigen and antibody tests
AuNIs
Gold Nanoislands

POC
Point of Care

CLIA
Chemiluminescence Enzyme Immunoassay

STOPCovid
SHERLOCK Testing on One Pot

SVM
Support Vector Machine

02 engineering and technology
01 natural sciences
CRISPR
Clustered Regularly Interspaced Short Palindromic Repeats

Analytical Chemistry
SHERLOCK
Specific High Sensitivity Enzymatic Reporter UnLOCKing

MERS-CoV
Middle East Respiratory Syndrome Coronavirus

ORF
Open Reading Frame

IoMT
Internet of Medical Things

Net
Neural Network

ddPCR
Droplet digital PCR

Diagnostic screening
CT
Chest Computed Tomography

Spectroscopy
education.field_of_study
IgA
Immunoglobulins A

Point (typography)
N
Nucleocapsid protein

AuNPs
Gold Nanoparticles

Ct
Cycle Threshold

IgM
Immunoglobulins M

0210 nano-technology
NGS
Next Generation Sequencing

Antibody detection
PPT
Plasmonic Photothermal

ssRNA
Single-Stranded Positive-Sense RNA

medicine.medical_specialty
2019-nCoV
2019 novel coronavirus

GISAID
Global Initiative on Sharing All Influenza Data

Article
WHO
World Health Organization

pfu
Plaque-forming unit

AI
Artificial Intelligence

NGM
Next Generation Molecular

LOC
Lab-on-a-Chip

Medical physics
ACE2
Angiotensin-Converting Enzyme 2

CAP
College of American Pathologists

education
pM
Picomolar

MS
Mass spectrometry

CG
Colloidal Gold

CLIA
Clinical Laboratory Improvement Amendments

nM
Nanomolar

RT-PCR
chest computerized tomography

BSL
Biosecurity Level

010401 analytical chemistry
VOC
Variant of Concern

DETECTR
SARS-CoV-2 DNA Endonuclease-Targeted CRISPR Trans Reporter

ICTV
International Committee on Taxonomy of Viruses

rS
Recombinant Spike protein antigen

0104 chemical sciences
OSN
One Step Single-tube Nested

m-RNA
Messenger Ribonucleic Acid

RBD
Receptor-binding domain

RT-PCR
Real-Time Reverse Transcription Polymerase Chain Reaction

RdRp
RNA-Dependent RNA Polymerase

LFIA
Lateral Flow Immunochromatographic Assays

Computer science
China CDC
Chinese Center for Disease Control and Prevention

SERS
Surface Enhanced Raman Spectroscopy

CCD
Charge-Coupled Device

SiO2@Ag
Complete silver nanoparticle shell coated on silica core

fM
Femtomolar

US CDC
US Centers for Disease Control and Prevention

dPCR
Digital PCR

GeneBank
Genetic sequence data base of the National Institute of Health

NSPs
Nonstructural Proteins

EUA
Emergence Use Authorization

FET
Field-Effect Transistor

PDMS
Polydimethylsiloxane

IoT
Internet of Things

LOD
Limit of detection

VTM
Viral Transport Medium

021001 nanoscience & nanotechnology
ALP
Alkaline Phosphatase

DNA
Dexosyrosyribonucleic Acid

IgG
Immunoglobulins G

MNP
Magnetic Nanoparticle

RNaseH
Ribonuclease H

Coronavirus disease 2019 (COVID-19)
NIH
National Institute of Health

R0
Basic reproductive number

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Population
ASOs
Antisense Oligonucleotides

LSPR
Localized Surface Plasmon Resonance

WGS
Whole Genome Sequencing

rN
Recombinant nucleocapsid protein antigen

QD
Quantum Dot

NER
Naked Eye Readout

S
Spike protein

medicine
RT-LAMP
Reverse Transcription Loop-Mediated Isothermal Amplification

Point of care
dNTPs
Nucleotides

SARS-CoV-2
ELISA
Enzyme Linked Immunosorbent Assay

COVID-19
RNA
Ribonucleic Acid

COVID-19
Coronavirus disease-19

Gold standard (test)
CGIA
Colloidal Gold Immunochromatographic Assay

aM
Attomolar

M
Membrane protein

FDA
Food and Drug Administration

SARS-CoV-2
Severe Acute Respiratory Syndrome Coronavirus 2

E
Envelope protein

RT
Reverse Transcriptase

Cas
CRISPR Associate Protein

EMA
European Medicines Agency
Zdroj: Microchemical Journal
ISSN: 0026-265X
DOI: 10.1016/j.microc.2021.106305
Popis: Since December 2019, we have been in the battlefield with a new threat to the humanity known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this review, we describe the four main methods used for diagnosis, screening and/or surveillance of SARS-CoV-2: Real-time reverse transcription polymerase chain reaction (RT-PCR); chest computed tomography (CT); and different complementary alternatives developed in order to obtain rapid results, antigen and antibody detection. All of them compare the highlighting advantages and disadvantages from an analytical point of view. The gold standard method in terms of sensitivity and specificity is the RT-PCR. The different modifications propose to make it more rapid and applicable at point of care (POC) are also presented and discussed. CT images are limited to central hospitals. However, being combined with RT-PCR is the most robust and accurate way to confirm COVID-19 infection. Antibody tests, although unable to provide reliable results on the status of the infection, are suitable for carrying out maximum screening of the population in order to know the immune capacity. More recently, antigen tests, less sensitive than RT-PCR, have been authorized to determine in a quicker way whether the patient is infected at the time of analysis and without the need of specific instruments.
Databáze: OpenAIRE